In a recent study published in Scientific Reports, researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and severe acute respiratory syndrome coronavirus 2 ...
Metastatic breast cancer (mBrCa) is most often an incurable disease with only modest responses to available immunotherapies. This study investigates the immunogenicity of somatic mutations in breast ...
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors Adoptive immunotherapy using tumor-infiltrating lymphocytes ...
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide ...
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient's own tumors, could provide ...
Vaccination efforts worldwide have drastically diminished morbidity and mortality rates for many infectious diseases, with some pathogens being entirely eradicated. However, to optimize long-term ...
In February, the FDA approved the first cancer therapy based on tumor-infiltrating lymphocytes (TILs). Although most advanced immunotherapies, such as CAR-Ts, have been largely aimed at blood-based ...
In a recent study, immune-inflammatory index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were associated with infection of respiratory syncytial virus (RSV) in children. High ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results